Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High dose rate endobronchial brachytherapy using a new applicator

Y Nomoto1, K Shouji, S Toyota

  • 1Department of Radiology, Mie University, School of Medicine, Tsu, Japan.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|November 19, 1997
PubMed
Summary

This study introduces a new applicator for endobronchial brachytherapy, improving dose distribution. The central source placement technique effectively treats lung cancer and reduces side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic effects of simultaneous intraluminal irradiation and intraluminal hyperthermia on oesophageal carcinoma.

The British journal of radiology·2001
Same author

Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung.

Shock (Augusta, Ga.)·1998
Same author

[Endobronchial brachytherapy with high dose rate 192Ir afterloading technique using a new applicator].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1996
Same author

[Simultaneous intraluminal irradiation and hyperthermia treatment for esophageal carcinoma].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1995
Same author

Inhibition of pulmonary hypertensive response after antigen challenge.

Shock (Augusta, Ga.)·1995
Same author

[Pulmonary hypertensive responses to erythrocytes components in sensitized rabbits].

Masui. The Japanese journal of anesthesiology·1995

Area of Science:

  • Oncology
  • Radiotherapy
  • Medical Physics

Background:

  • Endobronchial brachytherapy requires precise spatial dose distribution.
  • Current methods can lead to inhomogeneous dosage and side effects.
  • A novel applicator design is proposed to address these limitations.

Purpose of the Study:

  • To optimize spatial dose distribution in endobronchial brachytherapy.
  • To introduce a new applicator for high dose rate (HDR) brachytherapy.
  • To establish reference dose points based on bronchial diameter.

Main Methods:

  • Developed a new HDR brachytherapy applicator with a central source transfer tube.
  • Treated 39 patients with endobronchial cancer using Ir-192 source.
  • Prescribed reference dose points based on bronchial diameter measured by applicator wings.

Related Experiment Videos

  • Administered curative (40-60 Gy EBRT + 18 Gy brachytherapy) or palliative (10 Gy brachytherapy) regimens.

    • Main Results:

    • The new applicator was successfully placed in 37 out of 39 lesions.
    • Complete disappearance of lesions was observed in 67% (8/12) of curative intent cases.
    • Three-year overall survival was 22% for all patients and 64% for curative intent patients.

    Conclusions:

    • Positioning the source in the center of the bronchial lumen is crucial.
    • This technique effectively reduces side effects associated with inhomogeneous dose distribution.
    • The new applicator facilitates improved spatial dose control in endobronchial brachytherapy.